Efficacy in long-term treatment of depression

Journal of Clinical Psychiatry

Volumn 57, Issue SUPPL. 2, 1996, Pages 24-30

  Montgomery, Stuart A ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; IMIPRAMINE; LITHIUM; MAPROTILINE; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; PHENELZINE; PLACEBO; SEROTONIN ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RELAPSE; TREATMENT OUTCOME;

AMITRIPTYLINE; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; HUMANS; IMIPRAMINE; LONG-TERM CARE; PLACEBOS; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; SURVIVAL RATE; TREATMENT OUTCOME; TRIAZOLES;

EID: 0030002857     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Montgomery SA, Bebbington PE, Cowen P, et al. Guidelines for treating depressive illness with antidepressants. Journal of Psychopharmacology 1993;7:19-23
2. Montgomery SA, Racagni G, Coppen A, et al. Impact of neuropharmacology in the 1990s strategies for the therapy of depressive illness. Eur Neuropsychopharmacol 1993;3:153-156
3. Montgomery SA, Dufour H, Brion S, et al. The prophylactic efficacy of fluoxetine in unipolar depression. Br J Psychiatry 1988;153(suppl 3):69-76
4. Montgomery SA, Doogan DP, Burnside R. The influence of different relapse criteria on the assessment of long-term efficacy of sertraline. Int Clin Psychopharmacol 1991:6(suppl 2):37-46
5. Prien RF, Klett CH, Caffey EM. Lithium carbonate and imipramine in the prevention of affective episodes. Arch Gen Psychiatry 1973;29: 420-425
6. Seager CP, Bird RL. Imipramine with electrical treatment in depression: a controlled trial. Journal of Mental Science 1962;108:704-707
7. Klerman GL, Dimascio A, Weissman A, et al. Treatment of depression by drugs and psychotherapy. Am J Psychiatry 1974;131:186-191
8. Mindham RHS, Howland C, Shepherd M. An evaluation of continuation therapy with tricyclic antidepressants in depressive illnesses. Psychol Med 1973;3:5-17
9. Stein M, Rickels K, Weise CC. Maintenance therapy with amitriptyline: a controlled trial. Am J Psychiatry 1980;137:370-371
10. Prien RF, Kupfer DJ, Mansky PA, et al. Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders: report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and lithium carbonate-imipramine combination. Arch Gen Psychiatry 1984;41: 1096-1104
11. Rouillon F, Phillips R, Serrurier D, et al. Rechutes de depression unipolaire et efficacite de la maprotiline. Encephale 1989,15:527-534
12. Jacoby R, Lunn MA, Ardern M, et al How long should the elderly lake antidepressants? a double-blind placebo-controlled study of continuation/prophylaxis therapy with dothiepin Br J Psychiatry 1993;162: 175-182
13. Montgomery SA. Failure to demonstrate prophylactic efficacy of dothiepin [letter]. Br J Psychiatry 1993;163:257-258
14. Doogan DP, Caillard V. Sertraline in the prevention of depression. Br J Psychiatry 1992;160:217-222
15. Montgomery SA, Dunbar GC. Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression. Int Clin Psychopharmacol 1993;8:189-195
16. Montgomery SA, Rasmussen JGC, Tanghoj P. A 24 week study of 20 mg citalopram, 40 mg citalopram and placebo in the prevention of relapse of major depression, Int Clin Psychopharmacol 1993;8:181-188
17. Montgomery SA, Rasmussen JGC, Lyby K, et al. Dose response relationship of citalopram 20 mg, citalopram 40 mg, and placebo in the treatment of moderate and severe depression. Int Clin Psychopharmacol 1992;6 (suppl 5):65-70
18. Angst J. How recurrent and predictable is depressive illness? In: Montgomery SA, Rouillon F, eds. Long-term Treatment of Depression. Chichester. England: Wiley; 1992:1-14
19. Souza FGM, Goodwin GM. Lithium treatment and prophylaxis in unipolar depression: a meta-analysis. Br J Psychiatry 1991;158:666-675
20. Coppen A, Ghose K, Montgomery SA, et al. Continuation therapy with amitriptyline in depression. Br J Psychiatry 1979;133:28-33
21. Frank E, Kupfer DJ, Perel JM, et al. Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1990;47: 1093-1099
22. Georgotas A, McCue RE, Cooper TB. A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients. Arch Gen Psychiatry 1989;46:783-786
23. Robinson DS, Lerfald SC, Bennett B, et al. Continuation and maintenance treatment of major depression with the monoamine oxidase inhibitor phenelzine: a double-blind placebo-controlled discontinuation study. Psychopharmacology Bull 1991;15:527-534
24. Doogan DP, Caillard V. Sertraline in the prevention of depression. Br J Psychiatry 1992;160:217-222
25. Greenhouse JB, Stangl D, Kupfer DJ, et al. Methodological issues in maintenance therapy clinical trials. Arch Gen Psychiatry 1991;48:313-318
26. Anton SF, Robinson DS, Roberts DL, et al. Long-term treatment of depression with nefazodone. Psychopharmacol Bull 1994;30:165-169
27. Kupfer DJ, Frank E, Perel JM, et al. Five-year outcome for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1992;49:769-773
28. Frank E. Kupfer DJ, Perel JM, et al. Comparison of full-dose versus half-dose pharmacotherapy in the maintenance treatment of recurrent depression J Affect Disord 1993;27:139-145